Skip to content

A randomized clinical trial to assess the effect of repeated remote ischaemic postconditioning on infarct size in patients with an ischaemic stroke

A randomized clinical trial to assess the effect of repeated remote ischaemic postconditioning on infarct size in patients with an ischaemic stroke - Repeated RIPostC

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46558
Enrollment
200
Registered
2017-12-14
Start date
2018-04-23
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral vascular accident Ischaemic stroke

Interventions

Remote RIPostC: 4 cycles of ischaemia of the arm by inflating a simple blood pressure cuff around the upper arm at 20 mmHg above systolic blood pressure during 5 minutes followed by 5 minutes of rep

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Informed consent Age >18 years Clinically diagnosed ischaemic stroke using the WHO definition for stroke

Exclusion criteria

Exclusion criteria: Unstable vital signs Admitted >24 hours after onset of symptoms Upper extremity injury or edema contra-indicating RIPostC. Mastectomy on both sides

Design outcomes

Primary

MeasureTime frame
Difference in final infarct size between the intervention and control group. Infarct size will be measured using MRI.

Secondary

MeasureTime frame
The primary outcome (infarct size) will be linked to our secondary outcomes: Clinical outcome and vascular, immune, and anti-inflammatory pathways.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)